Anemia is a clinical condition where the human body does not have enough Red Blood Cells (RBC) or Haemoglobin or both which are paramount important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or low level of haemoglobin that leads to compromised supply of oxygen to various parts of the body that in turn causes fatigue. Vitamin tests are generally employed to ascertain the levels of vitamins in the body, these tests helps to diagnose the deficient or toxic levels of vitamins in a patient. Vitamin tests help doctors to device customised therapy options which are effective for disease management.
Anemia and Vitamin Test Market Drivers and Restraints, Segmentation, Region-wise Outlook and Key Players:
Anemia and vitamin test market is continue to witness positive growth owing to higher prevalence of Anemia and increased number of ageing population. According to WHO Report, Anemia affects nearly half of all pregnant women in the world: 52% in developing countries compared with 23% in the developed world. Apart from this, changing in diet pattern, lifestyle and increased awareness among consumers, chronic diseases. Technology up gradation perhaps positively impact Anemia and vitamin test market over the forecast period. High level of political and economic tension in Middle East countries and economic slowdown in China may hamper the growth of Anemia and vitamin test market over the forecast period.
Global anemia and vitamin test market has been segmented on the basis of test, reagents, technology, end user and region. Based on the test type: Anemia Test, Ferritin Test, Transferritin Test, Serum Iron Test, Retinol Test, 25-Hydroxy Vitamin D Test, 1, 25-Dihydroxy Vitamin D Test, Vitamin E Test, Vitamin K Test, Thiamine Test, Vitamin C Test; Based on the technology type: Chemiluminescence immunoassay (CLIA), Immunoassays (IA), Enzyme immunoassay (EIA), Radio immunoassay (RIA), Enzyme linked immunoasarbant assay (ELISA); Based on the end user: Hospitals, Diagnostic Laboratories.
Global anemia and vitamin test market is undergoing drastic changes due to the announcement of mergers & acquisition, collaborations and agreements between the companies. With the advent of new technologies in the given market which is expected to prompt the patients from using laboratory facilities to point of care (POC) tests may change the market dynamics over a given period of forecast. Merging of small lab chains into big chains proves to be concentration of revenues from small players to big players. By test type, segments such as Vitamin D test and anemia tests in the global anemia and vitamin test market are expected to grow in positive traction owing to higher prevalence of anemia and ageing population.
Geographically, anemia and Vitamin Test Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe will remain key markets for Anemia and vitamin test market due to availability of good reimbursement policies and increased attention for diagnostic tests among health care professionals. Other than China Asia Pacific is anticipated to register positive growth owing to government initiatives, increased consumer awareness and presence of key players in the region.
Some of the key players in the Global anemia and Vitamin Test Market are Abbott Laboratories, bioMérieux Inc., DiaSorin S.p.a., F. Hoffmann-La Roche, Siemens AG, DIAsource ImmunoAssays SA, Gold Standard Diagnostics, Immunodiagnostic Systems Holdings PLC, Ortho Clinical Diagnostics Inc., Qualigen Inc., Quest Diagnostics, Tosoh Bioscience, Takeda Chemical Ind, Eisai Co., Ltd, Yip rees technology development co., ltd
A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/11140